ELUTIA INC. — Investor Relations & Filings

Elutia Inc. is a biotechnology company that develops and commercializes proprietary drug-eluting biomaterial platforms designed to improve patient outcomes following medical device implantation and soft tissue reconstruction. The company's technology integrates natural biologic materials with extended-release drug delivery to combat post-surgical complications, reduce fibrotic responses, and promote healthy wound healing. Its key products include CanGaroo, an acellular biologic envelope for securing implantable electronic devices such as pacemakers and defibrillators, and SimpliDerm, a human acellular dermal matrix used for soft tissue repair and replacement. Elutia's mission is to enhance the compatibility between medical devices and patients, aiming to reduce implant failures and associated healthcare costs.